Cancer stem cells revisited

By E. Batlle, Hans Clevers. Nature Medicine, 2017

2,360 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/af8cff406dcab71ee61f76cde78d7f75fd023aa6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. I. Liu
2. Ruei-Min Lu
3. Yu-Chyi Hwang
4. Pengfei Shi
5. H. Cui
6. Zhen Dong
7. Fei Chen
8. Gaichao Zhao

Citations in the corpus

• Development of therapeutic antibodies for the treatment of diseases (2020, background): “Cancer is an extremely heterogeneous disease, and only a few tumor cells with stem-like properties are able to initiate and sustain tumor development; these cells are often referred as tumor initiating cells or cancer stem cells (CSCs) [111].”
• Targeting cancer stem cell pathways for cancer therapy (2020, methodology): “3 The primary separation techniques are fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS).”